Wu, J., Cheng, J., Zhu, L., Gao, Q., Lin, H., Zeng, Y., . . . Mu, W. (2025). CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity. Journal for immunotherapy of cancer, 13(11), e012243. https://doi.org/10.1136/jitc-2025-012243
Citácia podle Chicago (17th ed.)Wu, Jia, et al. "CD5 Ablation Enhances Persistence and Antitumor Potency of Engineered T Cells by Mitigating Exhaustion and Promoting Cytotoxicity." Journal for Immunotherapy of Cancer 13, no. 11 (2025): e012243. https://doi.org/10.1136/jitc-2025-012243.
Citácia podľa MLA (8th ed.)Wu, Jia, et al. "CD5 Ablation Enhances Persistence and Antitumor Potency of Engineered T Cells by Mitigating Exhaustion and Promoting Cytotoxicity." Journal for Immunotherapy of Cancer, vol. 13, no. 11, 2025, p. e012243, https://doi.org/10.1136/jitc-2025-012243.